Logo image
IRO Home Research units Researcher Profiles
Sign in
Re: Can Early Single Dose Instillation of Epirubicin Improve Bacillus Calmette-Guerin Efficacy in Patients With Nonmuscle Invasive High Risk Bladder Cancer? Results From a Prospective, Randomized, Double-Blind Controlled Study
Letter/Communication

Re: Can Early Single Dose Instillation of Epirubicin Improve Bacillus Calmette-Guerin Efficacy in Patients With Nonmuscle Invasive High Risk Bladder Cancer? Results From a Prospective, Randomized, Double-Blind Controlled Study

Richard J. Sylvester, Willem Oosterlinck and Michael O'Donnell
The Journal of urology, Vol.181(1), pp.410-410
01/01/2009
DOI: 10.1016/j.juro.2008.09.053
PMID: 19010500

View Online

Abstract

Life Sciences & Biomedicine Science & Technology Urology & Nephrology

Details

Metrics

Logo image